REPORT ID 137320

Global Serine/Threonine Protein Kinase Chk1 Market Study 2016-2026, by Segment (CCT-244747, FS-105,

Publish Date
Nov-19
Pages
52
Format
Electronic (PDF)

ummary

The global Serine/Threonine Protein Kinase Chk1 market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. 
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
        CCT-244747
        FS-105
        GDC-0575
        Others
Demand Coverage (Market Size & Forecast,  Consumer Distribution):
        Clinic
        Hospital
        Others
Company Coverage (Sales data, Main Products & Services etc.):
        CanBas Co Ltd
        Cascadian Therapeutics Inc
        Eli Lilly and Company
        Genentech Inc
        ProNAi Therapeutics Inc
        Sareum Holdings Plc
        Vernalis Plc
Major Region Market
        North America
        Europe
        Asia-Pacific
        South America
        Middle East & Africa 
			   
Table of Content
1 Industry Overview
    1.1 Serine/Threonine Protein Kinase Chk1 Industry
        1.1.1 Overview
        1.1.2 Products of Major Companies
    1.2 Market Segment
        1.2.1 Industry Chain
        1.2.2 Consumer Distribution
    1.3 Price & Cost Overview
2 Serine/Threonine Protein Kinase Chk1 Market by Type
    2.1 By Type
       2.1.1 CCT-244747
       2.1.2 FS-105
       2.1.3 GDC-0575
       2.1.4 Others
    2.2 Market Size by Type
    2.3 Market Forecast by Type
3 Global Market Demand
    3.1 Segment Overview
        3.1.1 Clinic
        3.1.2 Hospital
        3.1.3 Others
    3.2 Market Size by Demand
    3.3 Market Forecast by Demand
4 Major Region Market
    4.1 Global Market Overview
        4.1.1 Market Size & Growth
        4.1.2 Market Forecast
    4.2 Major Region
        4.2.1 Market Size & Growth
        4.2.2 Market Forecast
5 Major Companies List
    5.1 CanBas Co Ltd (Company Profile, Sales Data etc.)
    5.2 Cascadian Therapeutics Inc (Company Profile, Sales Data etc.)
    5.3 Eli Lilly and Company (Company Profile, Sales Data etc.)
    5.4 Genentech Inc (Company Profile, Sales Data etc.)
    5.5 ProNAi Therapeutics Inc (Company Profile, Sales Data etc.)
    5.6 Sareum Holdings Plc (Company Profile, Sales Data etc.)
    5.7 Vernalis Plc (Company Profile, Sales Data etc.)
6 Conclusion